Skip to content

Medline, Inc. MDLN Restricted Cash

Restricted Cash at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$202M+153%
CorMedix logo
CorMedixCRMD
$656K
Acme United logo
Acme UnitedACU
$750K0.0%
Baxter International logo
Baxter InternationalBAX
McKesson logo
McKessonMCK
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$33.35B+7.3%
Enterprise value$43.67B
P/E39.6×
P/S1.3×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp
FCF margin6.4%+0.5pp

Returns & leverage

See full
Return on equity7.7%
Debt / equity1.1×
Current ratio4.4×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's restricted cash?
Medline, Inc. (MDLN) reported restricted cash of $2M in Q1 2026.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.